Heino Stass
Clinical PK CV
Wuppertal, NW, Germany
Wuppertal, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Redefining the treatment of Chagas disease: a review of recent clinical and pharmacological data for a novel formulation of nifurtimox.
Journal: PLoS neglected tropical diseases
Published: February 25, 2025
In vivo Metabolism of Nifurtimox and the Drug-Drug Interaction Potential Including its Major Metabolites.
Journal: Current drug metabolism
Published: April 28, 2023
Correction to "Structural and Mechanistic Investigation of the Unusual Metabolism of Nifurtimox".
Journal: Chemical research in toxicology
Published: April 18, 2023
Structural and Mechanistic Investigation of the Unusual Metabolism of Nifurtimox.
Journal: Chemical research in toxicology
Published: October 09, 2022
Nifurtimox for Treatment of Chagas Disease in Pediatric Patients: the Challenges of Applying Pharmacokinetic-Pharmacodynamic Principles to Dose Finding.
Journal: The AAPS journal
Published: April 19, 2022
Population Pharmacokinetics of Nifurtimox in Adult and Pediatric Patients With Chagas Disease.
Journal: Journal of clinical pharmacology
Published: December 16, 2021
Clinical investigation of the biopharmaceutical characteristics of nifurtimox tablets - Implications for quality control and application.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: March 11, 2021
Safety, tolerability and pharmacokinetics of emodepside, a potential novel treatment for onchocerciasis (river blindness), in healthy male subjects.
Journal: British journal of clinical pharmacology
Published: August 26, 2020
Biopharmaceutical Characteristics of Nifurtimox Tablets for Age- and Body Weight-Adjusted Dosing in Patients With Chagas Disease.
Journal: Clinical pharmacology in drug development
Published: June 25, 2020
Ciprofloxacin Dry Powder for Inhalation: Inspiratory Flow in Patients with Non-cystic Fibrosis Bronchiectasis.
Journal: Journal of aerosol medicine and pulmonary drug delivery
Published: March 09, 2019
Application of Physiologically-Based and Population Pharmacokinetic Modeling for Dose Finding and Confirmation During the Pediatric Development of Moxifloxacin.
Journal: CPT: pharmacometrics & systems pharmacology
Published: February 12, 2019
Last Updated: 09/26/2026